Galluzzi, Lorenzo
Article History
Received: 8 March 2021
Revised: 9 March 2021
Accepted: 10 March 2021
First Online: 24 March 2021
Conflict of interest
: L.G. reports research funding from Lytix, and Phosplatin (completed), consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, The Longevity Labs, Inzen, and the Luke Heller TECPR2 Foundation.
: Not applicable.